Richard Garr

Richard Garr discloses dealings in Palisade Bio, Inc. to SEC (Form 4). We count 59 filings; the first trade dates from 14 November 2007 and the latest from 27 January 2016.

The open-market side counts 2 purchases for €263k alongside 3 sales for €38k. Taken together, the purchases exceed the sales by €225k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 11 share grants and 5 option exercises.

The latest filing, published on 28 January 2016, reports an option exercise in Palisade Bio, Inc. The most recent open-market purchase was published on 4 January 2010, 6,152 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.